MRPS28 serves as a biomarker of diagnostic, prognostic, and immune modulation in pan-cancer and promotes breast cancer malignant phenotypes
Collectively, these findings imply that MRPS28 emerges as a potential diagnostic and prognostic biomarker across pan-cancer, with a potential oncogenic role in breast cancer progression. Furthermore, it may be a potential therapeutic target for various cancers.
Authors
- Jie Hu (ORCID: https://orcid.org/0000-0001-8282-4895)
- Fenggui Xue
- Haiyan Niu
- Shixing Wang
- Yunlong Lu
- Zhifei Luo
- Xiangdong Guo
- Rensang Cai
Institutions
- Academy of Medical Sciences (GB)
- Tianjin Medical University General Hospital (CN)
- Hainan Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-03-03
- DOI
- https://doi.org/10.3389/fimmu.2026.1680772
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00